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INTRODUCTION 
Since the widespread use of Cyclosporine, organ 
transplantation has become the treatment of choice 
for a growing number of terminally ill patients. 
Unfortunately, the number of procedures is limited 
by the scarcity of organ donors. The enlargement of 
indications of organ harvest and the use of 
suboptimal donors may lead to specific 
complications, as the transferral of malignancy by 
grafting cancerous organs. 
We report our experience in this rare but desastrous 
complication of transplantation. 
CASE REPORTS 
Donor 1 was a 30-year-old female died from 
nontraumatic cerebral hemorrhage. A multiorgan 
harvest was performed, and the liver and the left 
kidney were explanted and transplanted to recipient 
1 and 2, respectively. The right kidney was rejected 
for vascular and urological abnormalities. Necropsy 
revealed a nodule in the right kidney, and three 
hemorrhagic nodules in the right lung. 
Histopathological analysis of these nodules 
demonstrated the presence of a choriocarcinoma. 
Later serum analyses revealed very high levels of ß-
HCG. 
Recipient 1 was a-20-year-old female who received 
the left kidney from donor 1. Graft CT-scan 
demonstrated a 2-cm nodule, and the 
immunosuppression was immediately interrupted. 
Transplantectomy was performed on postoperative 
day 12 but ß-HCG levels rose in spite of systemic 
interferon treatment in a attempt to stimulate her 
immunity. A chemotherapy (actinomycin D and 
etoposide) was undergone, which succeeded in 
normalizing the ß-HCG levels. Two years later, the 
patient was retransplanted and since then shows no 
evidence of recurrence. 
Recipient 2 received the liver harvested  from donor 
1. His ß-HCG levels rose despite normal graft CT 
scan. He underwent chemotherapy (methotrexate)  
but its condition prohibited retransplantation. The 
patient died on day 39 from pulmonary 
complications, and autopsy showed 3 
choriocarcinoma metastasis in the hepatic graft. 
Donor 2 was a-35-year-old female died from a 
nontraumatic cerebral hemorrhage. Paraaortic 
adenopathy was noticed during multiorgan 
harvesting. The liver, the heart and the kidneys were 
transplanted in 4 different centers. The results of the 
histopathological examination demonstrated that the 
paraaortic and pulmonary nodes were positive for a 
disseminated epidermoid epithelioma, originating 
from the cervix uteri. 
Recipient 3 was a 25-year-old man who received the 
liver from donor 2 in our department. When the 
necropsy findings were known, the patient was 
reinstated on the transplantation waiting list. CT 
scan were inconclusive and the patient was 
retransplanted on postoperative day 7. No evidence 
of malignancy was detected on histopathological 
analysis examination on the graft. 
Donor 3 was a 55-year-old female who died from 
cerebral hemorrhage in another country. We 
received one kidney, and we found a 4-cm nodule in 
this organ. Frozen section of this lesion showed a 
renal adenocarcinoma and transplantation was 
aborted in our center and in the centers which 
received the other kidney and the heart from the 
same donor. 
DISCUSSION 
As these cases demonstrate, the transferral of 
malignancy with organ transplantation may rarely 
but dramatically complicate the postoperative 
outcome of recipients. Its medical management is 
difficult, and its psychological impacts on the 
recipients may be desastrous. The transplant centers, 
both small and large, must be prepared for such an 
eventuality. Due to the organ shortage, the 
transplant teams enlarge the indications of 
harvesting, accepting older donors for instance, but 
the "malignant" donors must be avoided. 
PREVENTION 
 The use of donors with previously successfully 
treated cancer should be totally excluted, excepted 
the primary supratentorial cerebral tumors.  
 Careful examination of the abdomen and the 
thorax must be performed during the harvesting. 
 Histopathological analysis of suspected nodules 
must be available before the transplantation. 
 Peroperative echography and postharvesting 
autopsy may be helpful. 
 The level of ß-HCG must be available in female 
donors died from cerebral hemorrhage. 
TREATMENT 
Kidney transplantation 
 -Immunosuppression must be discontinued. 
 -Graft must be explanted.  
 -Specific chemotherapy must be initiated if 
 primary tumor is proven sensitive to treatment. 
Liver transplantation 
 -Hepatic allografts are not immediately 
 expandable, and they must remain in situ until 
 another graft is available. 
 -Specific chemotherapy must be initiated if 
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